# MEP and Neuromuscular Blocker

> **NCT04768400** · NA · COMPLETED · sponsor: **Gangnam Severance Hospital** · enrollment: 100 (actual)

## Conditions studied

- Brain Tumor

## Interventions

- **DRUG:** Arm I (MEP)

## Key facts

- **NCT ID:** NCT04768400
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-09
- **Primary completion:** 2022-05-13
- **Final completion:** 2022-05-13
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04768400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04768400, "MEP and Neuromuscular Blocker". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04768400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*